VPM
VOR icon

Vanguard Portfolio Management’s Vor Biopharma VOR Stock Holding History

Vanguard Portfolio Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.27M Buy
+340,364
New +$5.15M ﹤0.01% 2369

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Portfolio Management's VOR Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Vor Biopharma (VOR) in Q2 2026: 340,364 shares worth $6.27M. The stake represents ﹤0.01% of the portfolio and ranks #2369 among its holdings.

51 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Vanguard Portfolio Management held 340,364 shares of Vor Biopharma worth $6.27M as of Q2 2026.
  • Vor Biopharma was a new Vanguard Portfolio Management position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2369 holding.
  • 51 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.